ARS Pharmaceuticals, Inc. SPRY Change in Other Assets
Change in Other Assets at other companies
Other financials
Where this comes from
Reported directly by ARS Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets.
The official record: ARS Pharmaceuticals, Inc.’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →
Ask your AI about ARS Pharmaceuticals, Inc.'s change in other assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is ARS Pharmaceuticals, Inc.'s change in other assets?
- ARS Pharmaceuticals, Inc. (SPRY) reported change in other assets of $524K in Q1 2026.
- How has ARS Pharmaceuticals, Inc.'s change in other assets changed year-over-year?
- ARS Pharmaceuticals, Inc.'s change in other assets decreased by 89.1% year-over-year, from $4.8M to $524K.
- What is the long-term trend for ARS Pharmaceuticals, Inc.'s change in other assets?
- Over 4 years (2021 to 2025), ARS Pharmaceuticals, Inc.'s change in other assets has grown at a -13.5% compound annual growth rate (CAGR), from -$1.17M to -$656K.
- What does change in other assets mean?
- Change in miscellaneous assets affecting operating cash flow.